All
ACell Vet unveils powder for injection as ligament, tendon treatment
January 1st 2004ACell Vet, Inc. releases ACell Vet Powder for injection as a treatment for ligament and tendon injuries in equine patients. The release is based on results from a study that examined the effect of treatment using ACell Vet Powder, suspended in sterile saline, for injuries in suspensory ligaments and superficial digital flexor tendons.
Fort Dodge Animal Health launches combo vaccine targeting WNV and related mosquito-borne diseases
January 1st 2004Fort Dodge Animal Health introduces West Nile combination vaccines to protect horses against West Nile Virus (WNV), and all strains of encephalomyelitis. The U.S. Department of Agriculture recently approved the line of West Nile-Innovator/Encephalomyelitis combination vaccines.
Web-based tool aids in practice performance evaluation
January 1st 2004IDEXX, supplier of Cornerstone practice management software, is offering a new Web-based consultation option to help evaluate practice performance. The IDEXX team will host several live Internet consultations designed in conjunction with their Practice Profile product to help veterinarians chart practice growth, discover opportunities for increased sales, monitor client compliance and compare fees, protocols and revenue against regional and national averages.
Iowa regulators back off pet food industry; FDAsteps in
January 1st 2004Des Moines-Food and Drug Administration (FDA) officials eased an Iowa crackdown on pet foods containing glucosamine and chondroitin last month with its resolution to review animal supplements, stripping the issue from the state's jurisdiction.
Quality of health care: Do we practice what we preach?
January 1st 2004A recent study published in the New England Journal of Medicine attempted to evaluate the quality of care provided to patients by comparing medical records from hospitals with the standard "evidence-based" best practice relative to the patient's particular medical problem.
New therapy approved for control of canine atopic dermatitis
January 1st 2004Veterinarians now have a safe and effective non-steroidal option for long-term control of canine atopic dermatitis. Atopica, which contains the active ingredient cyclosporine A (CsA), has been approved by the U.S. Food and Drug Administration (FDA) for Novartis Animal Health.